甲地孕酮

jiǎ dì yùn tóng
  • megestrol
甲地孕酮甲地孕酮
  1. 甲地孕酮下调IL-6提高晚期肿瘤患者放化疗的耐受性

    Megestrol Improved Toleration to Radiotherapy and Chemotherapy for Patients with Advanced Cancer through Descending Level of Serum IL-6

  2. 甲孕酮和甲地孕酮植入家兔丘脑下部的抗排卵作用

    Anti-ovulatory effect of hypothalamic medroxyprogesterone or megestrol implants in the rabbit

  3. RP-HPLC法测定人血清中醋酸甲地孕酮浓度

    Determination of Megestrol Acetate with HPLC in Human Serum

  4. 甲地孕酮与三苯氧胺联合应用对乳腺癌MCF-7细胞生长和凋亡的影响

    Effect of tamoxifen and megestrol acetate on growth and apoptosis in MCF-7 breast cancer cell strain in vitro

  5. 扫描方式为选择反应监测(SRM),用于定量分析的二级碎片离子m/z分别为327.4(醋酸甲羟孕酮)和325.4(醋酸甲地孕酮,内标)。

    The scanner mode was selection response monitor ( SRM ) . The second order fragment ion of monitor was at 327.4 ( medroxyprogesterone acetate ) and m / z 325.4 ( megestrol acetate , internal standard ) .

  6. 方法;选择女性晚期乳腺癌病例共24例以大剂量甲地孕酮(HDMA)治疗(1200mg/d);

    Methods : 24 women with advanced breast cancer were treated with HDMA ( 1200mg / d ) .

  7. 建立了醋酸甲地孕酮软胶囊的溶出度测定方法。以2%十二烷基硫酸钠的乙酸盐缓冲液(pH4.5)900ml为溶出介质,转速120r/min,并考察了溶出曲线。

    The dissolution of megestrol acetate soft capsules was investigated , using 2 % Sodium dodecyl sulfate in acetate buffer solution ( pH4.5 ) as the dissolution medium , at the rotational rate of 120r / min. The dissolution curve was discussed .

  8. 醋酸甲地孕酮胶囊与美可治溶出度研究

    Comparative study on dissolution of megestrol acetate capsules and Megace tablets

  9. 一种尼尔雌醇-甲地孕酮周期新疗法

    A New Therapy With Nylestriol-Megestrol Acetate in Sequential Cyclic Treatment

  10. 大剂量甲地孕酮治疗晚期乳腺癌的内分泌激素改变

    Hormone changes of advanced breast cancer patients in high-dose megace

  11. 甲地孕酮Ⅱ型硅橡胶阴道避孕环多中心临床研究

    A multicentre clinical study of type ⅱ megestrol silicone contraceptive vaginal ring

  12. 甲地孕酮提高肿瘤患者化疗耐受性的临床研究

    A Clinical Study on Megestrol Improving Chemotherapy Tolerance in Patients with Cancer

  13. 复方甲地孕酮微囊注射液对大鼠垂体前叶超微结构的影响

    Effect of injection of microencapsulated compound megestrol acetate on ultrastructure of adenohypophysis

  14. 甲地孕酮对改善消化道肿瘤患者生存质量的观察

    Megestrol acetate enhances quality of life in patients with digestive system neoplasms

  15. 醋酸甲地孕酮预防化疗引起的消化道反应的临床研究

    Megestrol Acetate Used To Prevent Chemotherapy-induced Gastrointestinal Reactions : A Clinical Trial

  16. 炔诺酮和甲地孕酮对大鼠血浆脂蛋白代谢的影响

    The Effects and Mechanism of Norethisterone and Megestrol on Lipoprotein Metabolism in Rats

  17. 甲地孕酮在鼻咽癌同步放化疗中的作用

    Effects of megestrol acetate in concurrent chemotherapy for the patients with nasopharyngeal carcinoma

  18. 甲地孕酮;晚期恶性肿瘤;生活质量;生存期。

    Megestrolacetate ; advanced malignant neoplasm ; quality of life ; life span .

  19. 男性健康志愿者口服大剂量甲地孕酮的药物动力学和相对生物利用度

    Pharmacokinetics and relative bioavailability of megestrol at high doses in healthy male volunteers

  20. 差示脉冲极谱法测定避孕药中甲地孕酮的含量

    Determination of megestrol acetate in ampules for contraception by differential pulse polarographic method

  21. 甲地孕酮极谱性质的研究

    A Study of the Polarographic Characteristics of Megestrol Acetate

  22. 甲地孕酮防治肿瘤化疗中白细胞减少的临床研究

    Clinical study on megestrol acetate in the prevention of leucopenia due to chemotherapy

  23. 醋酸甲地孕酮与血浆蛋白的结合

    Studies on plasma protein binding of megestrol acetate

  24. 甲地孕酮在家兔和大鼠的药物动力学

    Pharmacokinetics of megestrol acetate in rabbits and rats

  25. 复方甲地孕酮注射液、醋酸甲地孕酮和雌二醇的生殖毒理研究

    Embryotoxic and Teratogenic Studies on megestrol compound injection , megestrol acetate and estradiol-17 β

  26. 醋酸甲地孕酮对晚期癌症患者生活质量的影响

    The Effect of MEGACE to the Quality of Life in Patients with Advanced Carcinoma

  27. 甲地孕酮硅橡胶阴道环避孕机制的探讨

    Mechanism of Megestrol Acetate-Releasing Silastic Intravaginal Ring

  28. 大剂量醋酸甲地孕酮改善肝癌患者生活质量的观察

    Using flushing dose megestrol acetate improve the quality of life in patients with hepatic carcinoma

  29. 甲地孕酮改善晚期胃癌患者生活质量的作用

    Effect of megestrol acetate in improving the quality of life in patients with advanced gastric cancer

  30. 多西他塞联合甲地孕酮治疗激素抵抗性前列腺癌疗效观察

    Analyses of clinical results of treatment with docetaxel and megestrol acetate for treating hormone-resistance prostate carcinoma